Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Thy-1+ Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis.

Schliekelman MJ, Creighton CJ, Baird BN, Chen Y, Banerjee P, Bota-Rabassedas N, Ahn YH, Roybal JD, Chen F, Zhang Y, Mishra DK, Kim MP, Liu X, Mino B, Villalobos P, Rodriguez-Canales J, Behrens C, Wistuba II, Hanash SM, Kurie JM.

Sci Rep. 2017 Jul 25;7(1):6478. doi: 10.1038/s41598-017-06922-5.

2.

Cancer-Associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma.

Pankova D, Chen Y, Terajima M, Schliekelman MJ, Baird BN, Fahrenholtz M, Sun L, Gill BJ, Vadakkan TJ, Kim MP, Ahn YH, Roybal JD, Liu X, Parra Cuentas ER, Rodriguez J, Wistuba II, Creighton CJ, Gibbons DL, Hicks JM, Dickinson ME, West JL, Grande-Allen KJ, Hanash SM, Yamauchi M, Kurie JM.

Mol Cancer Res. 2016 Mar;14(3):287-95. doi: 10.1158/1541-7786.MCR-15-0307. Epub 2015 Dec 2.

3.

Deregulated MicroRNAs in Cancer-Associated Fibroblasts from Front Tumor Tissues of Lung Adenocarcinoma as Potential Predictors of Tumor Promotion.

Negrete-Garcia MC, Ramírez-Rodriguez SL, Rangel-Escareño C, Muñoz-Montero S, Kelly-García J, Vázquez-Manríquez ME, Santillán P, Ramírez MM, Ramírez-Martínez G, Ramírez-Venegas A, Ortiz-Quintero B.

Tohoku J Exp Med. 2018 Oct;246(2):107-120. doi: 10.1620/tjem.246.107.

4.

Abundant tumor promoting stromal cells in lung adenocarcinoma with hypoxic regions.

Nakamura H, Ichikawa T, Nakasone S, Miyoshi T, Sugano M, Kojima M, Fujii S, Ochiai A, Kuwata T, Aokage K, Suzuki K, Tsuboi M, Ishii G.

Lung Cancer. 2018 Jan;115:56-63. doi: 10.1016/j.lungcan.2017.11.013. Epub 2017 Nov 20.

PMID:
29290263
5.

Podoplanin expression in cancer-associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung adenocarcinoma.

Kubouchi Y, Yurugi Y, Wakahara M, Sakabe T, Haruki T, Nosaka K, Miwa K, Araki K, Taniguchi Y, Shiomi T, Nakamura H, Umekita Y.

Histopathology. 2018 Feb;72(3):490-499. doi: 10.1111/his.13390. Epub 2017 Nov 27.

PMID:
28881047
6.

Clinicopathological significance of caveolin-1 expression by cancer-associated fibroblasts in lung adenocarcinoma.

Shimizu K, Kirita K, Aokage K, Kojima M, Hishida T, Kuwata T, Fujii S, Ochiai A, Funai K, Yoshida J, Tsuboi M, Ishii G.

J Cancer Res Clin Oncol. 2017 Feb;143(2):321-328. doi: 10.1007/s00432-016-2285-2. Epub 2016 Oct 22.

PMID:
27771795
7.

A novel method to generate single-cell-derived cancer-associated fibroblast clones.

Hashimoto H, Suda Y, Miyashita T, Ochiai A, Tsuboi M, Masutomi K, Kiyono T, Ishii G.

J Cancer Res Clin Oncol. 2017 Aug;143(8):1409-1419. doi: 10.1007/s00432-017-2409-3. Epub 2017 Mar 31.

PMID:
28364361
8.

In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer.

Grzeskowiak CL, Kundu ST, Mo X, Ivanov AA, Zagorodna O, Lu H, Chapple RH, Tsang YH, Moreno D, Mosqueda M, Eterovic K, Fradette JJ, Ahmad S, Chen F, Chong Z, Chen K, Creighton CJ, Fu H, Mills GB, Gibbons DL, Scott KL.

Nat Commun. 2018 Jul 16;9(1):2732. doi: 10.1038/s41467-018-04572-3.

9.

FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer.

Camolotto SA, Pattabiraman S, Mosbruger TL, Jones A, Belova VK, Orstad G, Streiff M, Salmond L, Stubben C, Kaestner KH, Snyder EL.

Elife. 2018 Nov 26;7. pii: e38579. doi: 10.7554/eLife.38579.

10.

Podoplanin-positive cancer-associated fibroblast recruitment within cancer stroma is associated with a higher number of single nucleotide variants in cancer cells in lung adenocarcinoma.

Nakasone S, Mimaki S, Ichikawa T, Aokage K, Miyoshi T, Sugano M, Kojima M, Fujii S, Kuwata T, Ochiai A, Tsuboi M, Goto K, Tsuchihara K, Ishii G.

J Cancer Res Clin Oncol. 2018 May;144(5):893-900. doi: 10.1007/s00432-018-2619-3. Epub 2018 Mar 6.

PMID:
29511884
11.

Identification of tumorigenic cells in Kras(G12D)-induced lung adenocarcinoma.

Cho HC, Lai CY, Shao LE, Yu J.

Cancer Res. 2011 Dec 1;71(23):7250-8. doi: 10.1158/0008-5472.CAN-11-0903. Epub 2011 Nov 16.

12.

Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.

Moatassim-Billah S, Duluc C, Samain R, Jean C, Perraud A, Decaup E, Cassant-Sourdy S, Bakri Y, Selves J, Schmid H, Martineau Y, Mathonnet M, Pyronnet S, Bousquet C.

Oncotarget. 2016 Jul 5;7(27):41584-41598. doi: 10.18632/oncotarget.9296.

13.

Fibroblast-led cancer cell invasion is activated by epithelial-mesenchymal transition through platelet-derived growth factor BB secretion of lung adenocarcinoma.

Neri S, Miyashita T, Hashimoto H, Suda Y, Ishibashi M, Kii H, Watanabe H, Kuwata T, Tsuboi M, Goto K, Menju T, Sonobe M, Date H, Ochiai A, Ishii G.

Cancer Lett. 2017 Jun 1;395:20-30. doi: 10.1016/j.canlet.2017.02.026. Epub 2017 Mar 9.

PMID:
28286261
14.
15.

Podoplanin-expressing cancer-associated fibroblasts lead and enhance the local invasion of cancer cells in lung adenocarcinoma.

Neri S, Ishii G, Hashimoto H, Kuwata T, Nagai K, Date H, Ochiai A.

Int J Cancer. 2015 Aug 15;137(4):784-96. doi: 10.1002/ijc.29464. Epub 2015 Feb 20.

16.

Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.

Zhang MY, Liu XX, Li H, Li R, Liu X, Qu YQ.

Int J Med Sci. 2018 Nov 5;15(14):1676-1685. doi: 10.7150/ijms.28728. eCollection 2018.

17.

Carcinoma associated fibroblasts (CAFs) promote breast cancer motility by suppressing mammalian Diaphanous-related formin-2 (mDia2).

Dvorak KM, Pettee KM, Rubinic-Minotti K, Su R, Nestor-Kalinoski A, Eisenmann KM.

PLoS One. 2018 Mar 29;13(3):e0195278. doi: 10.1371/journal.pone.0195278. eCollection 2018.

18.

miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1.

Roybal JD, Zang Y, Ahn YH, Yang Y, Gibbons DL, Baird BN, Alvarez C, Thilaganathan N, Liu DD, Saintigny P, Heymach JV, Creighton CJ, Kurie JM.

Mol Cancer Res. 2011 Jan;9(1):25-35. doi: 10.1158/1541-7786.MCR-10-0497. Epub 2010 Nov 29.

19.

Cancer-Associated Fibroblasts Accelerate Malignant Progression of Non-Small Cell Lung Cancer via Connexin 43-Formed Unidirectional Gap Junctional Intercellular Communication.

Luo M, Luo Y, Mao N, Huang G, Teng C, Wang H, Wu J, Liao X, Yang J.

Cell Physiol Biochem. 2018;51(1):315-336. doi: 10.1159/000495232. Epub 2018 Nov 19.

20.

Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer.

Tan X, Carretero J, Chen Z, Zhang J, Wang Y, Chen J, Li X, Ye H, Tang C, Cheng X, Hou N, Yang X, Wong KK.

PLoS One. 2013 Nov 15;8(11):e80885. doi: 10.1371/journal.pone.0080885. eCollection 2013.

Supplemental Content

Support Center